Patiromer sorbitex calcium
Indication
For treating hyperkalaemia (TA 623)
Red
Brand:
Veltassa®
Nice TA:
623
Commissioning responsibility:
CCG
PbR excluded:
No
BNF chapter:
Blood and Nutrition
Background
1.1 Patiromer is recommended as an option for treating hyperkalaemia in adults only if used:
• in emergency care for acute life-threatening hyperkalaemia alongside standard care or
• for people with persistent hyperkalaemia and stages 3b to 5 chronic kidney disease or heart failure, if they:
• have a confirmed serum potassium level of at least 6.0 mmol/litre and
• are not taking, or are taking a reduced dosage of, a renin-angiotensinaldosterone system (RAAS) inhibitor because of hyperkalaemia and
• are not on dialysis.
Recommendation
LSCMMG Recommendation:
Red
Reason for decision:
Specialist medicine
Supporting documents: